StockNews.com Initiates Coverage on TherapeuticsMD (NASDAQ:TXMD)

Equities research analysts at StockNews.com began coverage on shares of TherapeuticsMD (NASDAQ:TXMD) in a research report issued to clients and investors on Friday. The brokerage set a “hold” rating on the stock.

TherapeuticsMD Stock Up 0.5 %

Shares of TherapeuticsMD stock opened at $1.90 on Friday. The firm’s 50 day moving average is $2.27 and its 200 day moving average is $2.34. TherapeuticsMD has a 1 year low of $1.86 and a 1 year high of $4.73.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. ADAR1 Capital Management LLC acquired a new stake in shares of TherapeuticsMD during the fourth quarter valued at about $612,000. Clearline Capital LP increased its stake in shares of TherapeuticsMD by 8.6% in the second quarter. Clearline Capital LP now owns 455,372 shares of the company’s stock valued at $1,876,000 after buying an additional 35,947 shares during the period. BlackRock Inc. raised its holdings in TherapeuticsMD by 18.1% in the 2nd quarter. BlackRock Inc. now owns 137,127 shares of the company’s stock valued at $565,000 after buying an additional 20,995 shares during the last quarter. State Street Corp lifted its holdings in shares of TherapeuticsMD by 13.6% during the first quarter. State Street Corp now owns 30,130 shares of the company’s stock worth $113,000 after purchasing an additional 3,600 shares during the period. Finally, Geode Capital Management LLC lifted its holdings in TherapeuticsMD by 22.2% during the 1st quarter. Geode Capital Management LLC now owns 81,781 shares of the company’s stock worth $307,000 after buying an additional 14,835 shares during the period. 30.74% of the stock is currently owned by institutional investors and hedge funds.

About TherapeuticsMD

TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.